Literature DB >> 24385536

Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling.

Katarzyna Mleczko-Sanecka1, Franziska Roche, Ana Rita da Silva, Debora Call, Flavia D'Alessio, Anan Ragab, Philip E Lapinski, Ramesh Ummanni, Ulrike Korf, Christopher Oakes, Georg Damm, Lorenza A D'Alessandro, Ursula Klingmüller, Philip D King, Michael Boutros, Matthias W Hentze, Martina U Muckenthaler.   

Abstract

The hepatic hormone hepcidin is a key regulator of systemic iron metabolism. Its expression is largely regulated by 2 signaling pathways: the "iron-regulated" bone morphogenetic protein (BMP) and the inflammatory JAK-STAT pathways. To obtain broader insights into cellular processes that modulate hepcidin transcription and to provide a resource to identify novel genetic modifiers of systemic iron homeostasis, we designed an RNA interference (RNAi) screen that monitors hepcidin promoter activity after the knockdown of 19 599 genes in hepatocarcinoma cells. Interestingly, many of the putative hepcidin activators play roles in signal transduction, inflammation, or transcription, and affect hepcidin transcription through BMP-responsive elements. Furthermore, our work sheds light on new components of the transcriptional machinery that maintain steady-state levels of hepcidin expression and its responses to the BMP- and interleukin-6-triggered signals. Notably, we discover hepcidin suppression mediated via components of Ras/RAF MAPK and mTOR signaling, linking hepcidin transcriptional control to the pathways that respond to mitogen stimulation and nutrient status. Thus using a combination of RNAi screening, reverse phase protein arrays, and small molecules testing, we identify links between the control of systemic iron homeostasis and critical liver processes such as regeneration, response to injury, carcinogenesis, and nutrient metabolism.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24385536      PMCID: PMC3945866          DOI: 10.1182/blood-2013-07-515957

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  74 in total

1.  SMAD-mediated modulation of YY1 activity regulates the BMP response and cardiac-specific expression of a GATA4/5/6-dependent chick Nkx2.5 enhancer.

Authors:  Kyu-Ho Lee; Samuel Evans; Todd Y Ruan; Andrew B Lassar
Journal:  Development       Date:  2004-08-25       Impact factor: 6.868

Review 2.  Liver regeneration: from myth to mechanism.

Authors:  Rebecca Taub
Journal:  Nat Rev Mol Cell Biol       Date:  2004-10       Impact factor: 94.444

3.  Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle.

Authors:  E Mascareno; M Dhar; M A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

4.  Hepcidin in iron overload disorders.

Authors:  George Papanikolaou; Michalis Tzilianos; John I Christakis; Dionisios Bogdanos; Konstantina Tsimirika; Julie MacFarlane; Y Paul Goldberg; Nikos Sakellaropoulos; Tomas Ganz; Elizabeta Nemeth
Journal:  Blood       Date:  2005-01-25       Impact factor: 22.113

Review 5.  RASA1: variable phenotype with capillary and arteriovenous malformations.

Authors:  Laurence M Boon; John B Mulliken; Miikka Vikkula
Journal:  Curr Opin Genet Dev       Date:  2005-06       Impact factor: 5.578

6.  Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.

Authors:  Elizabeta Nemeth; Marie S Tuttle; Julie Powelson; Michael B Vaughn; Adriana Donovan; Diane McVey Ward; Tomas Ganz; Jerry Kaplan
Journal:  Science       Date:  2004-10-28       Impact factor: 47.728

7.  Multigenic control of hepatic iron loading in a murine model of hemochromatosis.

Authors:  Mounia Bensaid; Séverine Fruchon; Christine Mazères; Seiamak Bahram; Marie-Paule Roth; Hélène Coppin
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

8.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.

Authors:  Elizabeta Nemeth; Seth Rivera; Victoria Gabayan; Charlotte Keller; Sarah Taudorf; Bente K Pedersen; Tomas Ganz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  YY1 facilitates the association of serum response factor with the c-fos serum response element.

Authors:  S Natesan; M Gilman
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

10.  Hepcidin is decreased in TFR2 hemochromatosis.

Authors:  Elizabeta Nemeth; Antonella Roetto; Giovanni Garozzo; Tomas Ganz; Clara Camaschella
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

View more
  32 in total

Review 1.  Modulation of hepcidin to treat iron deregulation: potential clinical applications.

Authors:  Nicole L Blanchette; David H Manz; Frank M Torti; Suzy V Torti
Journal:  Expert Rev Hematol       Date:  2015-12-15       Impact factor: 2.929

2.  The small molecule ferristatin II induces hepatic hepcidin expression in vivo and in vitro.

Authors:  Ahmed A Alkhateeb; Peter D Buckett; Andrew M Gardeck; Jonghan Kim; Shaina L Byrne; Paula G Fraenkel; Marianne Wessling-Resnick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-04-23       Impact factor: 4.052

3.  Hydrogen Sulfide Attenuates Inflammatory Hepcidin by Reducing IL-6 Secretion and Promoting SIRT1-Mediated STAT3 Deacetylation.

Authors:  Hong Xin; Minjun Wang; Wenbo Tang; Zhuqing Shen; Lei Miao; Weijun Wu; Chengyi Li; Xiling Wang; Xiaoming Xin; Yi Zhun Zhu
Journal:  Antioxid Redox Signal       Date:  2015-09-03       Impact factor: 8.401

Review 4.  The Iron age of host-microbe interactions.

Authors:  Miguel P Soares; Günter Weiss
Journal:  EMBO Rep       Date:  2015-10-16       Impact factor: 8.807

Review 5.  Biomarkers of Nutrition for Development (BOND)-Iron Review.

Authors:  Sean Lynch; Christine M Pfeiffer; Michael K Georgieff; Gary Brittenham; Susan Fairweather-Tait; Richard F Hurrell; Harry J McArdle; Daniel J Raiten
Journal:  J Nutr       Date:  2018-06-01       Impact factor: 4.798

6.  Cellular citrate levels establish a regulatory link between energy metabolism and the hepatic iron hormone hepcidin.

Authors:  Ana Rita da Silva; Joana Neves; Katarzyna Mleczko-Sanecka; Amol Tandon; Sven W Sauer; Matthias W Hentze; Martina U Muckenthaler
Journal:  J Mol Med (Berl)       Date:  2017-06-05       Impact factor: 4.599

7.  The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.

Authors:  Silvia Colucci; Alessia Pagani; Mariateresa Pettinato; Irene Artuso; Antonella Nai; Clara Camaschella; Laura Silvestri
Journal:  Blood       Date:  2017-09-01       Impact factor: 22.113

8.  In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.

Authors:  S R Burstein; F Valsecchi; H Kawamata; M Bourens; R Zeng; A Zuberi; T A Milner; S M Cloonan; C Lutz; A Barrientos; G Manfredi
Journal:  Hum Mol Genet       Date:  2018-01-01       Impact factor: 6.150

9.  Acute hepatic ischemic-reperfusion injury induces a renal cortical "stress response," renal "cytoresistance," and an endotoxin hyperresponsive state.

Authors:  Richard A Zager; Ali C M Johnson; Kirsten B Frostad
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-30

Review 10.  Hepcidin regulation in the anemia of inflammation.

Authors:  Chia-Yu Wang; Jodie L Babitt
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.